Cañada, Mica .

HRN: 21-10-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2025
CEFUROXIME 1.5GM (VIAL)
01/11/2025
01/12/2025
IVT
1.5g
Ptor
ECtopic Pregnancy
Waiting Final Action 
01/11/2025
CEFUROXIME 1.5GM (VIAL)
01/11/2025
01/12/2025
IV
1.5grams
Q8 X 3 Doses
S/P Pelvic Laparotomy
Waiting Final Action 
01/11/2025
MUPIROCIN 2%, 15G (TUBE)
01/11/2025
01/17/2025
TOPICAL
2%
OD
S/P Pelvic Laparotomy
Waiting Final Action 
01/11/2025
CLINDAMYCIN 300MG (CAP)
01/11/2025
01/17/2025
ORAL
300mg
TID
S/P Pelvic Laparotomy
Waiting Final Action 
01/11/2025
DOXYCYCLINE 100MG (CAP)
01/11/2025
01/17/2025
ORAL
100mg
BID
S/P Pelvic Laparotomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: